47

Hipertensi Dalam Kehamilan

Embed Size (px)

DESCRIPTION

med

Citation preview

  • KLASIFIKASI :Report on the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy (AJOG Vol 183:S1, July 2000)

    HIPERTENSI GESTASIONAL :DIDAPATKAN DESAKAN DARAH 140/90 mmHg PERTAMA KALINYA PD KEHAMILAN, TDK DISERTA DGN PROTEINURIA DAN DESAKAN DARAH KEMBALI NORMAL < 12 MGG PASCA PERSALINAN

  • PREECLAMSIA :KRITERIA MINIMUMDESKAN DARAH 140/90 mmHg UMUR KEHAMILAN 20 MGG, DISERTAI PROTEINURIA 300 mg/24 JAM ATAU DIPSTICK 1 +

    ECLAMSIAKEJANG2 PADA PREECLAMPSIA DISERTAI KOMA

  • HIPERTENSI KRONIK DGN SUPERIMPOSED PREECLAMPSIA PROTEINURIA 300 MG/24 JAM PD HAMIL YG SUDAH MENGALAMI HIPERTENSI SEBELUMNYA. PROTEINURIA TIMBUL SETELAH KEHAMILAN 20 MGG

    HIPERTENSI KRONIKDITEMUKANNYA DESAKAN DARAH 140/90 mmHg, SEBELUM KEHAMILAN ATAU SEBELUM KEHAMILAN 20 MGG DAN TDK MENGHILANG SETELAH 12 MGG PASCA PERSALINAN

  • INTRODUCTION :INDUCED BY PREGNANCYDISEASE OF THEORIESCLINICAL MANIFESTATION : HYPERTENSION WITH OR WITHOUTORGAN DYSFUNCTION / FAILURE

    THIRD LEADING CAUSE OF MATERNAL MORTALITYMORTALITY RATE:150.000 WOMEN A YEAR WORLD WIDE

  • INCIDENCEPE/E : 2% - 9% OF ALL PREGNANT WOMEN IN SEVERAL HOSPITAL IN INDONESIA

    YEARHOSPITALPERCENTAGE AUTHOR1993 1997 1996 1997 1995 19982000 20022002RSPM12 HOSPITALSRS. H.S.RSHAM RSPMRSCM 5,750,8 - 1413,07,09,17SIMANJUNTAK J.TRIBAWONO A.MEIZIAGIRSANG. EPRIYATINI

  • ETIOLOGY : NOT FULLY KNOWNRISK FACTORS :NULLI PARITY / TEENAGE PREGNANCYHISTORY OF PREVIOUS PREGNANCYFAMILY HISTORY OF PE/EMULTIPLE GESTATIONPREEXISTING HYPERTENSION / RENAL DISEASED.M, ANTI PHOSPOLIPID ANTIBODYHYDROPS FETALISHYDATIDIFORM MOLESURYNARY TRACT INFECTION

  • PATHOGENESE : CONTROVERSION : THE DISEASE OF THEORIESIMMUNITY, GENETIC VASC. DISEASE TROPHOBLAST INADEQUATE TROPHOB. INVASION TO SPIRAL ARTERY OF PLACENTAINSUFF, PLACENTA HYPOXIAIUGROXYDATIVE STRESSENDOTHELIAL DYSFUNCTION CIRCULATING FACTOR(S) CYTOKINES LIPID (IL-6, TNF-) PEROXIDESNEUTROPHILACTIVATIONPLATELETACTIVATION

  • ENDOTHELIAL DYSFUNCTIONBLOOD

    THROMBOCYTOPENIA COAGULAPATHY

    ALTERED VASCULAR PERMEABILITY

    PERIPHERAL OEDEMA PULMONARY OEDEMASYSTEMIC VASOCONSTRICTION

    HYPERTENSIONKIDNEYS

    HYPERURICAEMIA PROTEINURIA RENAL FAILURELIVER

    ABNORMAL FUNCTION TESTS HAEMORRHAGECNS / EYES SEIZURES CORTICAL BLINDNESS RETINAL DETACHMENT & HAEMORRHAGE

  • CLINICAL CLASSIFICATION:PREECLAMPSIA-MILD-SEVERE

    IMPENDING ECLAMPSIAECLAMPSIAHELLP SYNDROME

  • MILD PREECLAMPSIA :BP 140/90 mmHg AFTER 20 WEEKS GESTATIONPROTEINURIA 300 mg/ 24 H OR 1+ DIPSTICKWITH OR WITHOUT OTHER SYMPTOMS AND SIGN

  • SEVERE PREECLAMPSIABP 160/110 mmHGPROTEINURIA 2.0 gr / 24 H OR 2 + DIPSTICKHEADACHE, VISUAL OR CEREBRAL DISTURBANCEEPIGASTRIC PAINOLIGURIA : < 400 500 CC/ 24 HOURS HYPER REFLEX, MOTORIC EXCITATION, IMPAIRED CONSIOUSNESS, SUDDEN DETERIORATION PLATELETS COUNT < 1000.000 / mm3BILIRUBIN 1,2 mg / DLLDH > 600 IU/LSGOT > 70 mg/DL

  • IMPENDING ECLAMPSIASEVERE PREECLAMPSIA WITH :HEADACHENAUSEA AND VOMITINGBLURRED VISION, SCOTOMA, IMPAIRED CONSIOUSNESS, SUDDEN DETERIORATIONEPIGASTRIC PAIN

  • ECLAMPSIA

    SEVERE PREECLAMPSIA + CONVULSION

    IS THE LEADING CAUSE OF 50.000 MATERNAL MORTALITY A YEAR WOLRD WIDE

    75% OCCURRED ANTEPARTUM AND 25% POST PARTUM

    40% OF SEIZURES OCCUR BEFORE HOSPITALIZATION

    CEREBRAL HAEMORRHAGE, PULMONARY EDEMAARE THE MOST COMMON COMPLICATION

  • HELLP SYNDROMECOMPLICATION OF SEVERE PREECLAMPSIA10-15% DIRECTLY FROM PREGNANCYMANAGEMENT OF PREECLAMPSIAADEQUAT AND PROPER PRENATAL CAREIDENTIFICATION OF WOMEN AT HIGH RISKEARLY DETECTION BY THE RECOGNATION OF CLINICAL SIGNS AND SYMPTOMS THE PROGRESSION OF CONDITION TO SEVERE STATE

  • MATERNAL AND PERINATAL OUTCOME IN WOMEN WITH MILD PREECLAMPSIA, > 36 WEEKS GESTATION ARE USUALLY FAVOURABLEMATERNAL AND PERINATAL OUTCOMES DEPEND ON :GESTATIONAL AGE AT TIME OF DISEASE ONSETSEVERITY OF DISEASEQUAITY OF MANAGEMENTPRESENCE OR ABSENCE OF PRE-EXISTING MEDICAL DISORDERS

  • MILD PREECLAMPSIAAMBULATORY CAREBED REST : NOT NECESSARILYREGULAR DIET, NO SALT RESTRICTIONPRENATAL VITAMINNO OTHER MEDICATION : ANTI HYPERTENSIVE, SEDATIVE, DIURETICSANTENAL VISIT : EVERY WEEK

  • HOSPITAL CAREPERSISTENT HYPERTENSION MORE THAN 2 WEEKSPERSISTENT PROTENURIA MORE THAN 2 WEEKSABNORMAL LABORATORY TESTABNORMAL FETAL GROWTHONE OR MORE SIGN AND SYMPTOM SEVERE PE

  • OBSTETRIC MANAGEMENTGESTATIONAL AGE < 37 WEEKS~SIGN AND SYMPTOM ARE NOT WORSENED MAINTAIN UNTIL TERM

    GESTATIONAL AGE > 37 WEEKS~WAIT UNTIL THE ONSET OF LABOR~CERVIX IS FAVORABLE, INDUCTION OF LABOR

  • SEVERE PREECLAMPSIAMEDICAL TREATMENT

    OBSTETRIC MANAGEMENT :CONSERVATIVE : -PREGNANCY 37 WEEKS

    ACTIVE: -PREGNANCY 37 WEEKS -FETAL INDICATION -MATERNAL INDICATION

  • MEDICAL TREATMENT :HOSPITALIZETOTAL BED RESTFLUID THERAPY : RINGER LACTATE, DEXTROSE 5%.Mg SO4 IVANTI HYPERTENSION :HYDRALAZINLABETALOLNIFEDIPINE :10 20 mg / ORALLY EVERY - 1 H,MAX : 120 mg / 24 HoursDIURETIC : NOT RECOMMENDEDANTI OXYDANT : N-ACETYL CYSTEINCORTICOSTEROID + LUNG MATURITY 34 WEEKS

  • OBSTETRIC MANAGEMENTCONSERVATIVE MANAGEMENT:GOAL : TO IMPROVE INFANT OUTCOME, WITHOUT COMPROMISING THE MOTHERPREGNANCY 37 WEEKS, IMPENDING ECLAMPSIA (-)

    ACTIVE MANAGEMENT : TO TERMINATE THE PREGNANCYINDICATIONFETAL : -PREGNANCY 37 WEEKS- IUGR AND ABNORMAL BIOPHYSICAL PROFILE

  • MATERNAL: - PERSISTENT HYPERTENTION- IMPENDING ECLAMPSIA -COMPLICATION : HELLP SYNDROME, ABRUPTIO PLAC., OLIGURIA

    ROUTE OF DELIVERY :VAGINAL DELIVERY IS PREFERABLE THAN CS.

  • ECLAMPSIA : PE + CONVULSIONBASIC MANAGEMENT :CONTROL THE AIRWAY, BREATHING, CIRCULATION (ABC)STABILIZE THE MOTHERCONTROL CONVULSIONCORRECT MATERNAL HYPOXEMIA / ACIDEMIAPREVENT COMPLICATION : HYPERTENSION CRISIS TERMINATE PREGNANCY

    MEDICAL TREATMENT :SAME AS SEVERE PREECLAMPSIA

  • COMPLICATION : P.E AND ECLAMPSIA

    MOTHERBABYHELLP SYNDROMELIVER RUPTUREDPULMONARY EDEMARENAL FAILUREABRUPTIO PLACENTAEDICCEREBROL VASCULER ACCIDENT MATERNAL DEATHIUGR PREMATURE LABORINTRA CRANIAL HAEMORRHAGECEREBRAL PALSYPNEUMO THORAXIUFD

  • HIPERTENSI KRONIK DALAM KEHAMILANDEFINISI KLINIK:HIPERTENSI YG DIDAPAT SEBELUM KEHAMILAN ATAU SEBELUM UMUR KEHAMILAN 20 MGG DAN HIPERTENSI TDK MENGHILANG SETELAH 12 MGG PASCA PERSALINAN

    ETIOLOGI HIPERTENSI KRONIK DALAM KEHAMILANPRIMER (IDIOPATIK) : 90 %SEKUNDER : 10 %, YG BERHUBUNGAN DGN PENY. GINJAL, PENY. ENDOKRIN (dm), PENY. HIPERTENSI DAN VASKULER

  • DIAGNOSISBERDASARKAN RISIKO :-RISIKO RENDAH : HIPERTENSI RINGAN TANPA DISERTAI KERUSAKAN ORGAN-RISIKO TINGGI :HIPERTENSI BERAT / HIPERTENSI RINGAN DISERTAI PERUBAHAN PATOLOGIS, KLINIS MAUPUN BIOLOGI KERUSAKAN ORGAN

    KRITERIA RISIKO TINGGI PD HIPERTENSI KRONIK DLM KEHAMILAN-HIPERTENSI BERAT : DESAKAN SISTOLIK 160 mmHg DAN DESAKAN DIASTOLIK 110 mmHg, SEBELUM 20 MGG KEHAMILAN

  • -HIPERTENSI RINGAN < 20 MGG KEHAMILAN DGN :PERNAH PREECLAMPSIAUMUR IBU > 40 THNHIPERTENSI 4 THNADANYA KELAINAN GINJALADANYA DIABETES MELLITUS (KLAS B KLAS F)KARDIOMIOPATIMEMINUMI OBAT ANTI HIPERTENSI SEBELUM HAMIL

  • KLASIFIKASI HIPERTENSI KRONIK(the 7th Report of the Joint National Committee (JNC 7)MIMs Cardiovascular Guide th. 2003 2004)

    KLASIFIKASISISTOLIK (mmHg)DIASTOLIK (mmHg)NORMALPREEHIPERTENSIHIPERTENSI STADIUM IHIPERTENSI STADIUM II< 120120 139140 159 160< 8080 8990 99 110

  • PENGELOLAAN HIPERTENSI KRONIK DLM KEHAMILAN:TUJUAN PENGOBATAN HIPERTENSI KRONIK DLM KEHAMILAN-MENEKAN RISIKO PD IBU KENAIKAN DESAKAN DARAH-MENGHINDARI PEMBERIAN OBAT2 YG MEMBAHAYAKAN JANIN

    PEMERIKSAAN LABORATORIUMPEMERIKSAAN (TEST) KLINIK SPESIALISTIK :-ECG-ECHOCARDIOGRAPHY-OPHTALMOLOGY-USG GINJAL

  • PEMERIKSAAN (TEST) LABORATORIUM-FUNGSI GINJAL :CREATININE SERUM BUN SERUM, ASAM URAT, PROTEINURIA 24 JAMPEMERIKSAAN PROTEINURIA SECARA PERIODIK-FUNGSI HEPAR-HEMATOLOGIK:Hb, HEMATOKRIT, TROMBOSIT

  • PEMERIKSAAN KESEJAHTERAAN JANIN ULTRASONOGRAPHY :- USG UTK DATA DASAR DIAMBIL 18-20 MGG KEHAMILAN-DIULANG PD UMUR KEHAMILAN 28-32 MGG DAN DIIKUTI SETIAP BLN-BILA DICURIGAI IUGR DI MONITOR DGN NST DAN PROFIL BIOFISIK

    HIPERETENSI KRONIK DLM KEHAMILAN DGN PENYULIT KARDIOVASKULER ATAU PENY. GINJAL PERLU MENDAPAT PERHATIAN KHUSUS

  • PENGOBATAN MEDIKAMENTOSAINDIKASI PEMBERIAN ANTIHIPERTENSI:RISIKO RENDAH HIPERTENSI:-IBU SEHAT DGN DESAKAN DIASTOLIK MENETAP 100 mmHg-DGN DISFUNGSI ORGAN DAN DESAKAN DIASTOLIK 90 mmHg

    OBAT ANTIHIPERTENSI-PILIHAN PERTAMA: METHYLDOPA : 0.5-3.0 g/hr, DIBAGI DLM 2-3 DOSIS.: NEFEDIPINE : 30-120 g/hr, DLM SLOW- RELEASE TABLET

  • PENGELOLAAN TERHADAP KEHAMILANSIKAP TERHDP KEHAMILANNYA PD HIPERTENSI KRONIK RINGAN : KONSERVATIF DILAHIRKAN SEDAPAT MUNGKIN PERVAGINAM PD KEHAMILAN ATERM.SIKAP TERHDP KEHAMILAN PD HIPERTENSI KRONIK BERAT : AKTIV SEGERA KEHAMILAN DIAKHIRI (DITERMINASI)ANESTESI : REGIONAL ANESTESI

    HIPERTENSI KRONIK DGN SUPERIMPOSED PREECLAMPSIAPENGELOLAAN HIPERTENSI KRONIK DGN SUPERIMPOSED PREECLAMPSIA SAMA DGN PENGELOLAAN PREECLAMPSIA BERAT.

  • HELLP SYNDROME PREGNANCYHYPERTENSION AND PROTEINURIAPREECLAMPSIAHELLP SYNDROME10-14% CASE

  • HELLP SYNDROMEFIRST DISCRIBED BY WEINSTEIN 1982:ACRONYM OF :H:HEMOLYSISEL:ELEVATED LIVER ENZYMLP:LOW PLATETLED COUNT

    INCIDENCE : 2%-12% AMONG PATIENTS WITH PREECLAMPSIA.30% OCCURS IN POSTPARTUM

  • CRITERIA DIAGNOSTICLABORATORY FINDING:HEMOLYSISABNORMAL PERIPHERAL SMEAR : SCHISTOCYTES AND BURR CELLSTOTAL BILIRUBIN LEVEL > 1,2 mg/DlLACTATE DEHYDROGENASE LEVEL > 600 /LELEVATED LIVER FUCTIONSGOT LEVEL 70 / L (LDH)LACTATE DEHYDROGENASE LEVEL > 600 /L

    LOW PLATELET COUNTPLATELET COUNT < 100.000/m3THE LABORATORY DIAGNOSTIC CRITERIA USED AT THE UNIVERSITY OF TENNESSEE DIVISION OF MATERNAL FETAL MEDECINE, MEMPHIS TN. WITLIN AND SIBAI (1999)

  • CLASS I : PLATELET 50.000/m3WITH : LDH 600 U/LSGOT 40 U/L

    CLASS II : PLATELET 50.000/m3 - < 100.000/m3 WITH : LDH 600 U/LSGOT 40 U/L

    CLASS II : PLATELET 50.000/m3 - < 150.000/m3 WITH : LDH 600 U/LSGOT 40 U/LCLASSIFICATION BASED ON PLATELET COUNT (MISSISIPPI):

  • MANAGEMENT OF HELLP SYNDROME

    MATERNAL STABILISATION IS THE MAYOR PRIORITY

    BEGIN WITH A STANDART MANAGEMENT OF SEVERE PREECLAMPSIA

    HELLP SYNDROME IS NOT AN INDICATION FOR CS

  • MEDICAL MANAGEMENT

    SAME AS SEVERE PREECLAMPSIA

    WHEN THROMBOCYTE COUNT IS < 50.000 mm3, 10 UNITS OF THROMBOCYTE OR FRESH WHOLE BLOOD MUST BE GIVEN

    WHEN PATIENT IS COMATOUS, SHE MUST BE TAKEN TO THE ICU

    WHEN THROMBOCYTE COUNTS IS < 50.000/mm3 FIBRINOGEN LEVEL, PROTHROMBINE TIME, PARTIAL THROMBOPLASTIN TIME, D-DIMMER MUST BE CHECKED TO FIND DIC

  • OBSTETRIC MANAGEMENTWHEN MOTHERS IS STABLE TERMINATE THE PREGNANCY OR CONSERVATIVE MANAGEMENT.

    CONSERVATIVE MANAGEMENT CAN BE DONE WHEN :THE BLOOD PRESSURE < 160/110 m gTHE OLIGURIA RESPONSE TO FLUID REPLACEMENTTHERE IS NO EPIGASTRIC PAINTHE GESTATIONAL AGE IS < 34 WEEKS

  • COMPLICATIONTHE COMPLICATIONS THAT CAN OCCUR IN HELLP SYNDROME ARE : NEUROLOGIC DISORDER, PULMONARY EDEMA, ABRUPTIO PLACENTA, DIC AND UGR

  • HYPERTENSION, PROTEINURIA AND OTHERS SYMPTOMS-SIGN OF PREECLAMPSIA ARE INDUCED BY PREGNANCY

    BESIDE HYPERTENSION AND PROTEINURIA, OTHER SYNDROMA OF PREECLAMPSIA ARE EPIGASTRIC PAIN, HEADCHE, VISUAL DISTURBANCE, OLIGURIA, CONVULSION, AND RENAL FAILURE.

    THERE ARE STILL CONTROVERSION IN CLASSIFICASION, DIAGNOSTIC AND MANAGEMENT OF PREGNANCY INDUCED HYPERTENSION.

    IN PATIENTS WITH MULTI ORGAN DYSFUNCTION / FAILURE MULTIDISIPLIN MANAGEMENT IS NEEDED.

    IGNORANCE, POVERTY, LATE ADMITTANCE TO HOSPITAL WILL INCREASE FERINATAL - MATERNAL, MORBIDITY AND MORTALITYCONCLUSIONS :

  • REFERENCES : Baker PN., Kingdom J., Preeclampsia Current Perspectives on Management. The Parthenon Publishing Group, New York, USA, 2004 page 133 143.

    Brown MA. Diagnosis and Classification of Preeclampsia and Hypertensive Disorders of Pregnancy in Belfort MA, Thornton S, Saade GR. Hypertension in Pregnancy, Marcel Dekker, Inc. New York, 2003, page 1 14.

    Dekker GA, Sibai BM. Ethiology and Pathogenesis of Preeclampsia : Current Concept. AmJ Obstet Gynecol 1998; 179 : 1359 75.

    Dikman AM, Hypertension in Pregnancy, Proposal for Clinical Practice Guide-line in Indonesia, 1st. ed. English Version, March 2005.

    Girsang ES. Analisa Tekanan Darah dan Proteinuria sebagai Faktor Prognosi. Kematian Maternal dan Perinatal pada Preeeklamsia Berat dan Eklamia. Tesis Bagian Obgin FK. USU RSUP. H. Adam Malik / RSUD Dr. Pirngadi Medan, 2004.

  • Robert JM, Carl A Hubel Oxydative Stress in Preeclampsia. AJOG 2004 : 190 : 117 8.

    Sibai BM; Diagnosis Prevention, and Management of Eclampsia, Obstetrics & Gynecology, vol 105, number 2, February 2005, page 405 410.

    Sibai BM, Gus Dekker GA, Michael Kupferminc Preeclampsia Lancet 2005, 365 : 785 99.

    Lipstein H, et al. Current Consept of Eclampsia. American Journal of Emergency Mediciene 203; 21 (3) : 233 7.

    Norwitz ER, Robinson JN, Rifke JT. Prevention of Preeclampsia : Is it Possible ? Clin Obstet Ginecology 1999, 42 (3) 436 54.

    Audibert F, et al. Clinical Utility of Strict Diagnostic Creteria for the HELLP (Hemolysis, Elevated Liver Enzymes, and Low Platelets) Syndorome AJOG 1996; 175 : 460 4.

    Weinstein L, Syndrome of Haemolysis, Elevated Liver Enzymes and Low Trombocyte Count : A severe Consequense of Hypertension in Pregnancy. Am J. Obstet Gynecol 1982; 42 : 159-167.

    James N, Martin Jr, MD, Carlh. Rose, MD, Christian M. Briery, MD. Understanding and Managing Hellp Syndrome : The Integral Role of Aggressive Glucocorticoids for Mother and Child. A Jog 2005. 08. 044.

  • Magann EF, Martin RW, Jsaacs JD, et al. Corticosteroids for the Enhancement of Fetal Lung Maturity : Impact on the Gravida with Preeclampsia and the HELLP Syndrome. Aust MZ J Obstet Gynecol 1993; 33 : 127 30.

    Martin JN, Perry KG, Blake PG, et al. Better Maternal Outcomes are Achieved with Dexamethasone Therapy for Postpartum HELLP (Hemolysis, Elevated Liver Enzymes and Low Thrombosit Counts) Syndrome. AmJ Obstet Gynecol 1997; 177 : 1011 7.

    Pedoman Penanganan Penderita Preeklamsia Berat dan HELLP Syndrome, Satgas Penanganan Penderita Preeklamsia Berat dan HELLP Syndrome Bagian / UPF Ilmu Kebidanan dan Penyakit Kandungan FK USU RSUD. Dr. Pirngadi Medan tahun 2002.